Skip to Content

Month: October 2021

Moderna says its Covid-19 vaccine was well-tolerated and generated robust immune response in children ages 6 to 11

By Jamie Gumbrecht, CNN Interim results of a Phase 2/3 trial showed Moderna’s Covid-19 vaccine was well-tolerated and generated a robust immune response in children ages 6 to 11, the company said Monday. The trial included more than 4,700 participants between the ages of 6 and 11, and looked at two 50-microgram doses of Moderna’s

Continue Reading